Company intelligence / Profile preview
Cymra Life Sciences
- Ownership
- Private
- Development stage
- Other
Overview
Cymra Life Sciences is running observational trials on chronic pain in collaboration with Applied Cannabis Research and CA Clinics. They develop full spectrum cannabis medicines targeting pharmaceutical and nutraceutical markets worldwide.
- Therapeutic areas
- ImmunologyPsychiatryNeurology
- Modalities
- Full spectrum cannabis medicinesPlant-based medicines
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Cymra Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cymra Life Sciences.